Myers E D, Calvert E J
Br J Clin Pharmacol. 1984 Jan;17(1):21-5. doi: 10.1111/j.1365-2125.1984.tb04993.x.
A study was carried out to elucidate whether the improved compliance associated with the provision of verbal and written information about a prescribed drug is due to the specific information or to a non-specific attention-placebo effect. 120 depressed outpatients were prescribed dothiepin and randomly allocated to one of three groups: Group A were given verbal and written information about side-effects; Group B were given verbal and written information about beneficial effects; Group C were told only that the drug was being given to treat their depression and received no written information. Compliance with medication was assessed at 3 weeks and 6 weeks by interrogation and by pill count. At the same time, side-effects were enquired for and their occurrence or non-occurrence noted. No significant differences were found between the groups in the rates of compliance at either 3 weeks or 6 weeks. When Groups A and B were combined to give a total 'information' group and compared with Group C--the 'no-information' group--the rate of compliance at 3 weeks was significantly higher (P less than 0.05) in the 'information' group. No significant differences were found between the groups in the rates of reported side-effects at either 3 weeks or 6 weeks. When Groups A and C were combined and compared with Group B (information about beneficial effects), side-effects were found to be reported significantly less frequently (P less than 0.05) in the latter at 6 weeks. Of 175 compliance estimates, 97.7% gave concordant results for estimation by interrogation and by pill count.(ABSTRACT TRUNCATED AT 250 WORDS)
开展了一项研究,以阐明与提供有关处方药的口头和书面信息相关的依从性改善是由于特定信息还是非特异性的注意力安慰剂效应。120名门诊抑郁症患者被开了多塞平,并随机分为三组:A组接受了关于副作用的口头和书面信息;B组接受了关于有益效果的口头和书面信息;C组仅被告知该药物用于治疗他们的抑郁症,未收到书面信息。通过询问和清点药丸在3周和6周时评估药物依从性。同时,询问副作用并记录其发生或未发生情况。在3周或6周时,各组之间的依从率没有显著差异。当A组和B组合并形成一个总的“信息”组并与C组(“无信息”组)进行比较时,“信息”组在3周时的依从率显著更高(P小于0.05)。在3周或6周时,各组之间报告的副作用发生率没有显著差异。当A组和C组合并并与B组(关于有益效果的信息)进行比较时,发现后者在6周时报告副作用的频率显著更低(P小于0.05)。在175次依从性评估中,97.7%的询问和清点药丸评估结果一致。(摘要截短于250字)